Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alkermes Q3 EPS $0.49 Beats $0.30 Estimate, Sales $394.185M Beat $356.099M Estimate

Author: Benzinga Newsdesk | October 28, 2025 06:02am
Alkermes (NASDAQ:ALKS) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.30 by 65.54 percent. This is a 12.5 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $394.185 million which beat the analyst consensus estimate of $356.099 million by 10.70 percent. This is a 4.24 percent increase over sales of $378.143 million the same period last year.

Posted In: ALKS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist